Edition:
United Kingdom

NanoVibronix Inc (NAOV.OQ)

NAOV.OQ on NASDAQ Stock Exchange Capital Market

4.50USD
20 Apr 2018
Change (% chg)

-- (--)
Prev Close
$4.50
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
3,292
52-wk High
$4.99
52-wk Low
$3.68

Select another date:

Thu, Apr 5 2018

BRIEF-Nanovibronix Signs Instrumed Surgical As Exclusive Distributor For UroShield Products In Canada

* NANOVIBRONIX INC - SIGNED INSTRUMED SURGICAL OF MISSISSAUGA, ONTARIO, CANADA AS ITS EXCLUSIVE DISTRIBUTOR FOR UROSHIELD PRODUCTS IN CANADA Source text for Eikon: Further company coverage:

BRIEF-Nanovibronix Inc - Signed Morulaa Healthtech As Its Regulatory And Marketing Partner In India

* NANOVIBRONIX INC - SIGNED MORULAA HEALTHTECH AS ITS REGULATORY AND MARKETING PARTNER IN INDIA Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

BRIEF-NanoVibronix Names IMS Ultrasound (UK) Ltd As Its Exclusive UK Distributor For Uroshield

* NANOVIBRONIX ANNOUNCES IMS ULTRASOUND (UK) LTD AS ITS EXCLUSIVE UK DISTRIBUTOR FOR UROSHIELD(TM) FOLLOWING SUCCESSFUL INTERIM TRIAL RESULTS

BRIEF-Nanovibronix Announces Exclusive U.K. Distributor For Painshield

* NANOVIBRONIX ANNOUNCES EXCLUSIVE UK DISTRIBUTOR FOR PAINSHIELD(TM) PROVIDING PATIENTS AN ALTERNATIVE TO OPIOIDS AND SURGERY

BRIEF-Nanovibronix ‍Expects To Complete Trial For Use Of Painshield In Patients With Trigeminal Neuralgia In Q1 Of 2018​

* NANOVIBRONIX REPORTS SUCCESSFUL INTERIM TRIAL RESULTS FOR USE OF PAINSHIELD(TM) IN PATIENTS WITH TRIGEMINAL NEURALGIA; REPRESENTS POTENTIAL ALTERNATIVE TO OPIOID AND SURGICAL INTERVENTIONS

Select another date: